BFS
CTSO icon

Bradley Foster & Sargent’s Cytosorbents Corp CTSO Stock Holding History

Bradley Foster & Sargent’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$15K – 468
2024
Q3 		$15K Hold
10,000
– – ﹤0.01% 457
2024
Q2 		$7.03K Hold
10,000
– – ﹤0.01% 444
2024
Q1 		$9.5K Hold
10,000
– – ﹤0.01% 439
2023
Q4 		$11.1K Hold
10,000
– – ﹤0.01% 426
2023
Q3 		$35.9K Hold
10,000
– – ﹤0.01% 429
2023
Q2 		$35.9K Hold
10,000
– – ﹤0.01% 429
2023
Q1 		$33.7K Sell
10,000
-2,000
-17% -$6K ﹤0.01% 426
2022
Q4 		$18.6K Buy
12,000
+2,000
+20% +$2.97K ﹤0.01% 423
2022
Q3 		$14K Hold
10,000
– – ﹤0.01% 419
2022
Q2 		$22K Hold
10,000
– – ﹤0.01% 433
2022
Q1 		$32K Sell
10,000
-250
-2% -$895 ﹤0.01% 466
2021
Q4 		$43K Sell
10,250
-23,990
-70% -$135K ﹤0.01% 445
2021
Q3 		$278K Sell
34,240
-6,500
-16% -$52.8K 0.01% 369
2021
Q2 		$308K Buy
40,740
+864
+2% +$7.28K 0.01% 356
2021
Q1 		$346K Buy
39,876
+736
+2% +$7.01K 0.01% 326
2020
Q4 		$312K Hold
39,140
– – 0.01% 332
2020
Q3 		$312K Buy
+39,140
New +$353K 0.01% 296
2020
Q1 		$254K Sell
32,890
-299
-0.9% -$1.51K 0.01% 299
2019
Q4 		$128K Sell
33,189
-12,308
-27% -$53.7K ﹤0.01% 353
2019
Q3 		$229K Sell
45,497
-73,254
-62% -$426K 0.01% 324
2019
Q2 		$785K Sell
118,751
-13,261
-10% -$91.1K 0.03% 230
2019
Q1 		$999K Sell
132,012
-17,966
-12% -$140K 0.03% 212
2018
Q4 		$1.21M Buy
149,978
+5,486
+4% +$54.5K 0.05% 188
2018
Q3 		$1.86M Buy
144,492
+4,926
+4% +$61.8K 0.06% 177
2018
Q2 		$1.59M Buy
+139,566
New +$1.32M 0.06% 189

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Bradley Foster & Sargent's CTSO Position: Q4 2024 in Review

Bradley Foster & Sargent sold out of Cytosorbents Corp (CTSO) in Q4 2024, closing a stake of 10,000 shares — an estimated $15K sold.

Bradley Foster & Sargent first reported a position in CTSO in Q2 2018 and held it in 25 quarters. The position peaked at $1.86M in Q3 2018. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

  • Bradley Foster & Sargent reported no remaining Cytosorbents Corp position as of Q4 2024 after selling out during the quarter.
  • Bradley Foster & Sargent sold 10,000 Cytosorbents Corp shares in Q4 2024, an estimated $15K.
  • Bradley Foster & Sargent first reported a position in Cytosorbents Corp in Q2 2018 and held it in 25 quarters.
  • Bradley Foster & Sargent's Cytosorbents Corp position peaked at $1.86M in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2024.

Based on Bradley Foster & Sargent's 13F filing for Q4 2024, filed 3 Feb 2025.